Official numbers are pending, but Reuters notes enrollment appears to be just 3% of the government's goal.
A roundup of some exchange-related news circling the web.
Benefits research studies show employers expect to lay out 7% more in healthcare costs in 2014, a move that has not been accompanied by lower employee costs.
Three studies take on different angles of the patient experience. Spoiler alert: no cost increases are mentioned.
A JAMA article says prostate cancer patients are getting treatments they don't need; Roche and AstraZeneca will share safety data; WellPoint gives cost sharing a new spin; Bayer seeks to boost its oncology pipeline; Takeda announces organizational changes; and the FDA puts Allergan's Restasis on track for generic competition.
Astellas teams up with Cytokinetics for muscle weakness research; ADA says lifestyle changes don't protect diabetics' hearts; AJMC talks pharmacists as diabetes counselors; and AARP helps with healthcare reform education.
JAMA's look into the impact of patient centric care shows that a broader scope is needed to understand the financial and health impact of active patients and how doctors perceive what it means to be engaged with patients.
A little over half of US girls ages 13 to 17 have not gotten even one dose of the HPV vaccine, and among the main reasons are poor awareness and the failure of doctors to recommend vaccination, a study shows.